CeleCor Therapeutics
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI (NCT04825743) | CeleCor Therapeutics | 2021-04-24 |
| A Phase 2 Open Label Study to Assess the PK/PD Properties of RUC-4 in Patients With a ST-elevation Myocardial Infarction (NCT04284995) | CeleCor Therapeutics | 2020-06-02 |
| A Randomized Phase 1 Dose-Escalation Study of Subcutaneously(SC) Administered RUC-4 (NCT03844191) | CeleCor Therapeutics | 2019-02-18 |
Track CeleCor Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.